R&D

Product Pipeline

R&D Platform

Business Development

After years of research and development, we have a balanced and diversified product pipeline with a strategic focus on dermatology and major cancers.

 
 

Note: 1.In addition, IND for basal-cell carcinoma indication has been cleared by FDA in the U.S.

 

Focus Us

Picture Name
Picture Name

WeChat

Copyright: Kintor Pharmaceutical Limited retains all copyrights.  苏ICP备19028699号-2  Powered by 300.cn  SEO Business License

Complaints and Suggestions Tel: +86 512 62639935 Email: public@kintor.com.cn

Copyright © 2024 Kintor Pharmaceutical Limited 版权所有

SEO Business License

Powered by:300.cn

Kintor